Revenue (Tables)

6 Months Ended

Jun. 30, 2019

Revenue

Schedule of reportable segment included under sales category

	Three Months Ended June 30, 2019						Three Months Ended June 30, 2018
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	853	$	853	$	—	$	866	$	866
Other		—		255		255		—		263		263
Total		—		1,108		1,108		—		1,129		1,129
Nutritionals —
Pediatric Nutritionals		475		576		1,051		469		582		1,051
Adult Nutritionals		311		513		824		312		495		807
Total		786		1,089		1,875		781		1,077		1,858
Diagnostics —
Core Laboratory		272		897		1,169		248		880		1,128
Molecular		38		69		107		38		84		122
Point of Care		113		32		145		108		31		139
Rapid Diagnostics		272		212		484		258		226		484
Total		695		1,210		1,905		652		1,221		1,873
Cardiovascular and Neuromodulation —
Rhythm Management		273		275		548		285		286		571
Electrophysiology		190		240		430		170		230		400
Heart Failure		149		52		201		117		46		163
Vascular		270		460		730		284		466		750
Structural Heart		152		200		352		118		197		315
Neuromodulation		168		44		212		173		49		222
Total		1,202		1,271		2,473		1,147		1,274		2,421
Other		167		451		618		122		364		486
Total	$	2,850	$	5,129	$	7,979	$	2,702	$	5,065	$	7,767

	Six Months Ended June 30, 2019						Six Months Ended June 30, 2018
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	1,605	$	1,605	$	—	$	1,659	$	1,659
Other		—		495		495		—		514		514
Total		—		2,100		2,100		—		2,173		2,173
Nutritionals —
Pediatric Nutritionals		928		1,152		2,080		917		1,128		2,045
Adult Nutritionals		605		982		1,587		622		947		1,569
Total		1,533		2,134		3,667		1,539		2,075		3,614
Diagnostics —
Core Laboratory		521		1,709		2,230		476		1,671		2,147
Molecular		78		137		215		77		163		240
Point of Care		222		58		280		218		62		280
Rapid Diagnostics		598		423		1,021		581		462		1,043
Total		1,419		2,327		3,746		1,352		2,358		3,710
Cardiovascular and Neuromodulation —
Rhythm Management		525		537		1,062		571		563		1,134
Electrophysiology		364		471		835		330		433		763
Heart Failure		292		93		385		231		85		316
Vascular		536		903		1,439		570		919		1,489
Structural Heart		288		388		676		227		381		608
Neuromodulation		320		85		405		341		93		434
Total		2,325		2,477		4,802		2,270		2,474		4,744
Other		327		872		1,199		216		700		916
Total	$	5,604	$	9,910	$	15,514	$	5,377	$	9,780	$	15,157

Note: Insertable Cardiac Monitor (ICM) sales, which had previously been reported in Electrophysiology, are now included in Rhythm Management. Historic periods have been adjusted to reflect this change.

Schedule of changes in contract liabilities

(in millions)
Contract Liabilities
Balance at December 31, 2018	$	259
Unearned revenue from cash received during the period		201
Revenue recognized that was included in contract liability balance at beginning of period		(163)
Balance at June 30, 2019	$	297